Activation and trafficking of peritoneal B1a B-cells in response to amphibole asbestos

References

• Antao, V. C., Larson, T. C., and Horton, D. K. 2012. Libby vermiculite exposure and risk of developing asbestos-related lung and pleural diseases. Curr. Opin. Pulm. Med. 18:161–167
   PubMed Web of Science ®Google Scholar
• Atencio, S., Amano, H., Izui, S., and Kotzin, B. L. 2004. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells. J. Immunol. 172:4159–4166
   PubMedGoogle Scholar
• Aust, A. E., Cook, P. M., and Dodson, R. F. 2011. Morphological and chemical mechanisms of elongated mineral particle toxicities. J. Toxicol. Environ. Health 14:40–75
   Google Scholar
• Bamba, H., Ishigaki, H., Ishida, H., et al 2005. B1-B-cells are the main antigen-presenting cells in CpG-ODN-stimulated peritoneal exudate cells. Microbiol. Immunol. 49:89–95
   PubMedGoogle Scholar
• Berberich, S., Dähne, S., Schippers, A., et al 2008. Differential molecular and anatomical basis for B-cell migration into the peritoneal cavity and omental milky spots. J. Immunol. 180:2196–2203
   PubMedGoogle Scholar
• Berry, K., and Martinic, G. 2005. Harvesting murine peritoneal cells: A methodology for the untrained research worker. Contemp. Top. Lab. Anim. Sci. 44:50–51
   PubMedGoogle Scholar
• Bouaziz, J. D., Yanaba, K., and Tedder, T. F. 2008. Regulatory B-cells as inhibitors of immune responses and inflammation. Immunol. Rev. 224:201–214
   PubMed Web of Science ®Google Scholar
• Broaddus, V. C., Everitt, J. I., Black, B., and Kane, A. B. 2011. Non-neoplastic and neoplastic pleural endpoints following fiber exposure. J. Toxicol. Environ. Health 14:153–178
   Web of Science ®Google Scholar
• Bunderson-Schelvan, M., Pfau, J. C., Crouch, R., and Holian, A. 2011. Non-pulmonary outcomes of asbestos exposure. J. Toxicol. Env. Health 14:122–152
   Google Scholar
• DeLillo, D. J., Matsushita, T., and Tedder, T. F. 2009. B10 cells and regulatory B-cells balance immune responses during inflammation, autoimmunity, and cancer. Ann. NY Acad. Sci. 1183:38–57
   Google Scholar
• Enghard, P., Humrich, J. Y., Chu, V. T., et al 2010. Class switching and consecutive loss of dsDNA-reactive B1a B-cells from the peritoneal cavity during murine lupus development. Eur. J. Immunol. 40:1809–1818
   PubMed Web of Science ®Google Scholar
• Fagarasan, S., Watanabe, N., Honjo, T. 2000. Generation, expansion, migration and activation of mouse B1 cells. Immunol. Rev. 176:205–215
   PubMedGoogle Scholar
• Gronwall, C., Vas, J., and Silverman, G. J. 2012. Protective roles of natural IgM antibodies. Front. Immunol. 3:66
   PubMed Web of Science ®Google Scholar
• Ha, S. A., Tsuji, M., Suzuki, K., et al 2006. Regulation of B1 cell migration by signals through Toll-like receptors. J. Exp. Med. 203:2541–2550
   PubMed Web of Science ®Google Scholar
• Hillion, S., Rochas, C., Youinou, P., and Jamin, C. 2005. Expression and reexpression of recombination activating genes: Relevance to development of autoimmune states. Ann. NY Acad. Sci. 1050:10–18
   PubMedGoogle Scholar
• Ishida, D., Su, L., Tamura, A., et al 2006. Rap1 signal controls B-cell receptor repertoire and generation of self-reactive B1a cells. Immunity 24:417–427
   PubMed Web of Science ®Google Scholar
• Ishida, H., Hastings, R., Kearney, J., and Howard, M. 1992. Continuous anti-IL-10 antibody administration depletes mice of Ly-1 B-cells but not conventional B-cells. J. Exp. Med. 175:1213–1220
   PubMed Web of Science ®Google Scholar
• Kaminski, D. A., and Stavnezer, J. 2006. Enhanced IgA class switching in marginal zone and B1 B-cells relative to follicular/B2 B-cells. J. Immunol. 177:6025–6029
   PubMed Web of Science ®Google Scholar
• Kane, A. B. 1992. Animal models of mesothelioma induced by mineral fibers: Implications for human risk assessment. Prog. Clin. Biol. Res. 374:37–50
   PubMedGoogle Scholar
• Kendall, P. L., Woodward, E. J., Hulbert, C., and Thomas, J. W. 2004. Peritoneal B-cells govern the outcome of diabetes in non-obese diabetic mice. Eur. J. Immunol. 34:2387–2395
   PubMed Web of Science ®Google Scholar
• Larson, T. C., Meyer, C. A., Kapil, V., et al 2010. Workers with Libby amphibole exposure: retrospective identification and progresssion of radiographic changes. Radiology 255:924–933
   PubMed Web of Science ®Google Scholar
• Lau, C. M., Broughton, C., Tabor, A. S., et al 2005. RNA-associated autoantigens activate B-cells by combined B-cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202:1171–1177
   PubMed Web of Science ®Google Scholar
• Marchand, D. L., St-Hilaire, S., Putnam, E. A., et al 2012. Mesothelial cell and anti-nuclear autoantibodies associated with pleural abnormalities in an asbestos exposed population of Libby MT. Toxicol. Lett. 208:168–173
   PubMed Web of Science ®Google Scholar
• Martin, F., and Kearney, J. F. 2001. B1 cells: Similarities and differences with other B-cell subsets. Curr. Opin. Immunol. 13:195–201
   PubMed Web of Science ®Google Scholar
• Mohan, C., Morel, L., Yang, P., and Wakeland, E. K. 1998. Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum. 41:1652–1662
   PubMed Web of Science ®Google Scholar
• Morbach, H., Singh, S. K., Faber, C., et al 2006. Analysis of RAG expression by peripheral blood CD5+ and CD5- B-cells of patients with childhood systemic lupus erythematosus. Ann. Rheum. Dis. 65:482–487
   PubMed Web of Science ®Google Scholar
• Murakami, M., Tsubata, T., Shinkura, R., et al 1994. Oral administration of lipopolysaccharide activates B-1 cells in the peritoneal cavity and lamina propria of gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J. Exp. Med. 180:111–121
   PubMed Web of Science ®Google Scholar
• Murakami, M., and Honjo T. 1995. Involvement of B-1 cells in mucosal immunity and auto-immunity. Immunol. Today 16:534–539
   PubMedGoogle Scholar
• Murakami, M., Yoshioka, H., Shirai, T., et al 1995. Prevention of auto-immune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int. Immunol. 7:877–882
   PubMed Web of Science ®Google Scholar
• Noonan, C. W., Pfau, J. C., Larson, T. C., and Spence, M. R. 2006. Nested case-control study of autoimmune disease in an asbestos-exposed population. Environ. Health. Perspect. 114:1243–1247
   PubMed Web of Science ®Google Scholar
• Peipins, L. A., Lewin, M., Campolucci, S., et al 2003. Radiographic abnormalities and exposure to asbestos-contaminiated vermiculite in the community of Libby, Montana, USA. Environ. Health Perspect. 111:1753–1759
   PubMed Web of Science ®Google Scholar
• Pfau, J. C., Blake, D. J., and Fritzler, M. 2009. Autoantibody profiles of an asbestos-exposed population. In: Autoimmunity: Role, Regulation and Disorders (Vogel, F. L., and Zimmerman, L. F., Eds.). New York: Nova Biomedical Books, pp. 245–268
   Google Scholar
• Pfau, J. C., Li, S., Holland, S., and Sentissi, J. J. 2011. Alternation of fibroblast phenotype by asbestos-induced autoantibodies. J. Immunotoxicol. 8:159–169
   PubMed Web of Science ®Google Scholar
• Pfau, J. C., Sentissi, J. J., Li, S., et al 2008. Asbestos-induced autoimmunity in C57BL/6 mice. J. Immunotoxicol. 5:129–137
   PubMed Web of Science ®Google Scholar
• Pfau, J. C., Sentissi, J. J., Weller, G., and Putnam, E. A. 2005. Assessment of autoimmune responses associated with asbestos exposure in Libby, Montana, USA. Environ. Health. Perspect. 113:25–30
   PubMed Web of Science ®Google Scholar
• Rasmussen, D. L., and Pfau, J. C. 2012. Asbestos activates CH12.LX B-lymphocytes via macro-phage signaling. J. Immunotoxicol. 9:129–140
   PubMed Web of Science ®Google Scholar
• Rohs, A. M., Lockey, J. E., Dunning, K. K., et al 2008. Low-level fiber-induced radiographic changes caused by Libby vermiculite: A 25-year follow-up study. Am. J. Respir. Crit. Care Med. 177:630–637
   PubMed Web of Science ®Google Scholar
• Sato, T., Ishikawa, S., Akadegawa, K., et al 2004. Aberrant B1 cell migration into the thymus results in activation of CD4 T-cells through its potent antigen-presenting activity in the development of murine lupus. Eur. J. Immunol. 34:3346–3358
   PubMedGoogle Scholar
• Smartt, A. M., Brezinski, M., Trapkus, M., et al 2010. Collagen accumulation over time in the murine lung after exposure to crocidolite asbestos or Libby amphibole. Environ. Toxicol. 25:68–76
   PubMed Web of Science ®Google Scholar
• Tuscano, J. M., Harris, G. S., and Tedder, T. F. 2003. B-Lymphocytes contribute to autoimmune disease pathogenesis: Current trends and clinical implications. Autoimmun. Rev. 2:101–108
   PubMedGoogle Scholar
• Webber, J. S., Blake, D. J., Ward, T. J., and Pfau, J. C. 2008. Separation and characterization of respirable amphibole fibers from Libby, Montana. Inhal. Toxicol. 20:733–740
   PubMed Web of Science ®Google Scholar
• Xu, Z., Butfiloski, E. J., Sobel, E. S., and Morel, L. 2004. Mechanisms of peritoneal B-1a cells accumulation induced by murine lupus susceptibility locus Sle2. J. Immunol. 173:6050–6058
   PubMed Web of Science ®Google Scholar
• Yanaba, K., Bouaziz, J. D., Haas, K. M., et al 2008. A regulatory B-cell subset with a unique CD1dhiCD5+ phenotype controls T-cell-dependent inflammatory responses. Immunity 28:639–650
   PubMed Web of Science ®Google Scholar
• Yang, Y., Tung, J. W., Ghosn, E. E., and Herzenberg, L. A. 2007. Division and differentiation of natural antibody-producing cells in mouse spleen. Proc. Natl. Acad. Sci. USA 104:4542–4546
   PubMed Web of Science ®Google Scholar
• Youinou, P., and Lydyard, P. M. 2001. CD5+ B-cells in non-organ-specific autoimmune diseases: a fresh look. Lupus 10:523–525
   PubMedGoogle Scholar
• Youinou, P., and Renaudineau, Y. 2007. The paradox of CD5-expressing B-cells in systemic lupus erythematosus. Autoimmun. Rev. 7:149–154
   PubMedGoogle Scholar